morpholinobacteriochlorins, that absorb light in the near-IR range and possess, in
comparison to regular porphyrins, unusually low fluorescence emission and 1O2 quantum
yields were tested with respect to their efficacy as novel molecular photo-acoustic imaging
contrast agents in a tissue phantom, providing an up to∼ 2.5-fold contrast enhancement
over that of the benchmark contrast agent ICG. The testing protocol compares the …